Back to search results

Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules

Abroad (travel likely)Recruiting

Conditions

Solitary Pulmonary Nodules · Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ziekenhuis Oost-Limburg, Genk, Limburg, Belgium

    Contact: Study coordinator (Jill Meynen) · jill.meynen@uhasselt.be · 003289804034
    Contact: Study coordinator (Liesbet Mesotten, prof. dr.)
    Contact: Principal Investigator (Liesbet Mesotten, prof. dr.)
    Jill Meynen (Sub-investigator)
Study leads

  • Liesbet Mesotten, prof. dr.

    Principal Investigator

    Ziekenhuis Oost-Limburg

  • Jill Meynen

    Study Chair

    Hasselt University

  • Elien Derveaux, dr.

    Study Chair

    Hasselt University

  • Wouter Marchal, prof. dr.

    Study Chair

    Hasselt University

View source on ClinicalTrials.gov(opens in a new tab)